Cargando…
Clinical Role of ASCT2 (SLC1A5) in KRAS-Mutated Colorectal Cancer
Mutation in the KRAS gene induces prominent metabolic changes. We have recently reported that KRAS mutations in colorectal cancer (CRC) cause alterations in amino acid metabolism. However, it remains to be investigated which amino acid transporter can be regulated by mutated KRAS in CRC. Here, we pe...
Autores principales: | Toda, Kosuke, Nishikawa, Gen, Iwamoto, Masayoshi, Itatani, Yoshiro, Takahashi, Ryo, Sakai, Yoshiharu, Kawada, Kenji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578022/ https://www.ncbi.nlm.nih.gov/pubmed/28749408 http://dx.doi.org/10.3390/ijms18081632 |
Ejemplares similares
-
Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression via CCR5
por: Nishikawa, Gen, et al.
Publicado: (2019) -
Metabolic Alterations Caused by KRAS Mutations in Colorectal Cancer Contribute to Cell Adaptation to Glutamine Depletion by Upregulation of Asparagine Synthetase()()
por: Toda, Kosuke, et al.
Publicado: (2016) -
Treatment of Elderly Patients with Colorectal Cancer
por: Itatani, Yoshiro, et al.
Publicado: (2018) -
Transforming Growth Factor-β Signaling Pathway in Colorectal Cancer and Its Tumor Microenvironment
por: Itatani, Yoshiro, et al.
Publicado: (2019) -
The Role of Tumor-Associated Neutrophils in Colorectal Cancer
por: Mizuno, Rei, et al.
Publicado: (2019)